<DOC>
	<DOCNO>NCT00409864</DOCNO>
	<brief_summary>Cancer gallbladder ( CaGB ) one common cause malignant obstructive jaundice . Jaundice second common presentation occur 30-60 % patient CaGB . It obstructive nature frequently associate pruritus , disturb patient . The usual mechanism obstruction direct infiltration bile duct tumour . Most patient CaGB obstructive jaundice amenable curative surgical resection hence effective palliation goal treatment . Although surgical bypass traditional palliative approach , associate substantial morbidity mortality . Non-operative alternative form percutaneous endoscopic drainage available . A trial show endoscopic drainage well percutaneous drainage patient low end bile duct obstruction due pancreatic peri-ampullary cancer . However , scenario quite different patient upper end bile duct obstruction occur due CaGB . Endoscopic drainage associate high incidence cholangitis patient block upper end bile duct success rate varies 40 % 80 % , percutaneous drainage may associate complication biliary leak bleeding . There randomized trial compare endoscopic percutaneous drainage patient malignant obstruction due CaGB . The objective present study carry randomize prospective trial compare percutaneous endoscopic biliary drainage patient CaGB obstructive jaundice ass quality life .</brief_summary>
	<brief_title>Endoscopic Versus Percutaneous Drainage For Hilar Block Gall Bladder Cancer</brief_title>
	<detailed_description>Hypothesis : Percutaneous biliary stenting superior endoscopic stenting provide successful biliary drainage 20 % patient unresectable malignant hilar block due carcinoma gall bladder . Background : Malignant biliary obstruction liver hilum cause heterogeneous group tumour include cholangiocarcinoma , gallbladder cancer ( CaGB ) metastatic cancer . CaGB common cause malignant hilar obstruction India ( 1 ) . Jaundice second common presentation occur 30-60 % patient CaGB ( 2-5 ) . It obstructive nature frequently associate pruritis , disturb patient . Most patient CaGB surgical obstructive jaundice amenable curative surgical resection ( 5 ) hence effective palliation goal treatment . Although surgical bilioenteric bypass traditional palliative approach ( 6 ) , associate substantial morbidity mortality . Non-operative alternative form percutaneous endoscopic drainage available ( 7-8 ) . Unilateral drainage single liver lobe may sufficient palliate jaundice , pruritis improve quality life ( 9-15 ) . A trial show endoscopic drainage well percutaneous drainage patient low end bile duct obstruction due pancreatic periampullary cancer . However , scenario quite different patient hilar malignant obstruction . Endoscopic drainage associate high incidence cholangitis patient block confluence ( Bismuth type 2 3 ) success rate varies 40 % 80 % , percutaneous drainage may associate complication biliary leak bleeding . There randomized trial compare endoscopic percutaneous drainage patient malignant hilar obstruction alone . Objective : To compare unilateral PTBD endoscopic stenting patient CaGB hilar block term Successful drainage Quality life Patients Methods Consecutive patient CaGB jaundice enrol study . The diagnosis CaGB biliary obstruction establish basis ultrasound abdomen dual phase CT scan . Histological and/or cytological confirmation malignancy establish wherever possible FNAC/trucut biopsy . Hilar block classify accord Bismuth Corlette classification base preprocedural investigation ( 16 ) . Final differentiation type 2 3 block base finding note intervention . Inclusion criterion CaGB hilar block suitable curative resection one follow criterion : ( ) Jaundice serum bilirubin &gt; 10 mg/dl , ( ii ) Pruritus , ( iii ) Cholangitis Exclusion criterion : Poor performance status : Karnofsky index &lt; 60 , Type 1 4 hilar block , Uncontrolled ascites , Duodenal obstruction , Patients opt insertion metallic stent . Sample size calculation : The number patient include calculated 91 patient group base assumption percutaneous drainage well endoscopic drainage 20 % . The sample size calculate formula power 80 % alpha error 0.05 . The patient randomly divide two group use random block generate computer . Group A - percutaneous biliary drainage ( PTBD ) Group B - Endoscopic stenting ( ES ) Pre-procedural preparation ( 17 ) Patients undergo detailed investigation inform consent obtain . The procedure perform conscious sedation ( midazolam pentozocine ) liberal infiltration local anesthetic site capsule liver PTBD . 1 . PTBD procedure ( 17 ) Either right left side approach use PTBD . Once entry gain suitable duct standard Seldinger technique use place guidewire biliary system . The tract dilate cross obstruction hydrophilic guidewire , ring biliary catheter place provide internal-external drainage . In subsequent session , 10 F , straight plastic stent ( polyurethane ) place system across obstruction provide internal drainage . 2 . Endoscopic stenting ( 18 ) A therapeutic duodenoscope standard sphincterotome use cannulation bile duct . A hydrophilic guidewire use cross malignant stricture . After stricture cross guide catheter pass guidewire 10 F straight plastic stent insert across stricture guidewire . Primary outcome measure : 1 . Successful drainage : A decrease bilirubin le 75 % pretreatment value within 7 day 2 . Early cholangitis : Occurring within 48 hour 7 day procedure evidence fever , leukocytosis worsen LFTs . 3 . Quality life Secondary outcome measure : 1 . Complications 2 . Procedure-related 30-day mortality 3 . Stent patency time define time stent occlusion . Hematological biochemical parameter assess day 2 7 , 1 month stent placement every 3 month thereafter . Patients re-evaluated 7 day , 1 month stent placement 3 month thereafter . Quality life assess use WHO-QOL BREF26 EORTC QLQ-30 questionnaire pre-procedure , 1 month 3 month . World Health Organization-QOL BREF-26 ( 19 ) This 26 item , cover physical , psychological , social environmental domain . The daily activity grade accordance 5 grade scale performance status recommend WHO . WHO-QOL domain score calculate use guideline give WHO-QOL score manual . A high score represent high level QOL . EORTC QLQ-30 ( 20 ) The EORTC QLQ-30 consist 30 generally applicable item . It incorporate functional scale ( item 1-5 ) , role function scale ( item 6,7 ) , general symptom scale ( item 8-19 ) , scale cognitive ( item 20-25 ) , emotional ( item 21-24 ) social ( item 26-27 ) functioning , financial strain scale ( item 28 ) global health status scale ( item 29,30 ) . Scoring do use EORTC score manual . A high score functional scale represent high/healthy level functioning , high score global health status/QOL represent high QOL high score symptom scale/item represent high level symptomatology/ problem . All patient instruct contact department , symptom suggestive complication appear . Additional information regard current status death obtain direct contact refer physician patient telephone/letter . Statistical analysis Data analyze accord intention-to-treat ( ITT ) per protocol ( PP ) method . The baseline characteristic express mean ( SD ) . The Pearson chi -square test Fischer exact test use comparison categorical data appropriate . The t-test use comparison continuous variable . Cumulative survival estimate use Kaplan-Meier life table analysis , group compare log rank chi-square test . The QOL score analysis do use Paired 't ' test comparison baseline 1 month baseline 3 month within group . MANOVA use assess trend score . References 1 . Malkan G , Mohandas KM . Epidemiology digestive cancer India . I . General principle esophageal cancer . Indian J Gastroenterol 1997 ; 16 ( 3 ) :98-102 2 . Wanebo HJ , Castle WN , Fechner RE . Is carcinoma gall bladder curable lesion ? Ann Surg 1982 ; 195:624-31 . 3 . Kelly TR , Chamberlain TR . Carcinoma gall bladder . Am J Surg 1982 ; 143:737-41 4 . Morrow CF , Sutherland DE , Florack G , Eisenberg MM , Grage TB . Primary carcinoma gall bladder : Significance subserosal lesion result aggressive surgical treatment adjuvant chemotherapy . Surgery 1983 ; 94:709-14 5 . Kumaran V , Gulati MS , Paul SB , Pande GK , Sahni P , Chattopadhyay TK . The role dual phase helical CT assess respectability carinoma gall bladder . Eur Radiol 2002 ; 12:1993-99 . 6 . Bismuth H , Castaing D , Traynor O. Resection palliation ; priority surgery treatment hilar cancer . World J Surg 1988 ; 12:39-47 . 7 . Huibregtse K , Tytgat GNJ . Palliative treatment jaundice transpapillary introduction biliary endoprosthesis . Gut 1982 ; 23:371-5 . 8 . Cotton PB . Endoscopic method relief malignant obstructive jaundice . World J Surg 1984 ; 8:854-61 . 9 . Dowsett JF , Vaira D , Hatfield AR , Cairns SR , Polydorou AA , Frost R , et al . Endoscopic biliary therapy use combine percutaneous endosopic route . Gastroenterology 1989 ; 96:1180-6 . 10 . Polydorou AA , Cairns SR , Dowsett JF , Hatfield AR , Salmon PR , Cotton PB , et al . Palliation proximal malignant biliary obstruction endoscopic endoprosthesis insertion . Gut 1991 ; 32:685-9 . 11 . De Palma GD , Galloro G , Sicilliano S , Ivonini P , Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage patient malignant hilar biliary obstruction : result prospective , randomize control study . Gastrointest Endosc 2001 ; 53:547-53 12 . Sherman S. Endoscopic drainage malignant hilar obstruction : one biliary stent enough place two ? Gastrointest Endosc 2001 ; 53:681-4 . 13 . Chang WH , Kortan P , Haber GB . Outcome patient bifurcation tumor undergo unilateral versus bilateral hepatic duct drainage . Gastrointest Endosc 1998 ; 47:354-62 14 . Mehta S , Ozden ZS , Dhanireddy S , Pleskow DP , Chutanni R. Endoscopic single versus double ( bilateral ) Wallstents palliation malignant Bismuth type III/IV hilar stricture : comparison clinical outcome cost ( abstract ) . Gastrointest Endosc 1999 ; 49 : AB234 . 15 . De Palma , Angelo Pezzullo , Maria Rega , Unilateral placement metallic stent malignant hilar obstruction : prospective study . Gastrointest Endosc 2003 ; 55:50-5 . 16 . Bismuth H , Castaing D , Traynor O. Resection palliation : priority surgery treatment hilar cancer . World j Surg 1988 ; 12:39-47 . 17 . Gulati MS , Srinivasan A , Agarwal PP . Percutaneous Management Malignant Biliary Obstruction : The Indian Perspective . Tropical Gastroenterology 2003 ; 24:47-58 . 18 . Ahuja V , Garg PK , Kumar D , Goindi G , Tandon RK . Presence white bile associate low survival malignant biliary obstruction . Gastrointest Endosc 2002 ; 55:186-91 . 19 . World Health Organization Handbook Reporting Results cancer Treatment . World Health Organization Publication No .48 Geneva World Health Organization 1979 . 20 . Aaronson NK , Ahmedzai S , Bergman B , Bullinger M , Cull A , Duez NJ et al . The European Organization Research Treatment Cancer QLQ-C30 : quality-of-life instrument use international clinical trial oncology . J Natl Cancer Inst 1993 ; 85:365-76 .</detailed_description>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Jaundice , Obstructive</mesh_term>
	<criteria>CaGB hilar block suitable curative resection one follow criterion : Jaundice serum bilirubin &gt; 10 mg/dl , Pruritus , Cholangitis Poor performance status : Karnofsky index &lt; 60 , Type 1 4 hilar block , Uncontrolled ascites , Duodenal obstruction , Patients opt insertion metallic stent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Gallbaldder Cancer</keyword>
	<keyword>Endoscopic stenting</keyword>
	<keyword>Percutaneous biliary drainage</keyword>
</DOC>